Cerevel Therapeutics
CERE
$42.31
Share price
0.17%
Change (1 day)
31.77%
Change (1 year)
Categories
Cerevel Therapeutics (CERE) - Cash on Hand
Cash on Hand as of December 2023 : $0.99 B
According to Cerevel Therapeutics's latest financial reports the company has $0.99 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Cerevel Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.99 B | 11.09% |
| 2022-12-31 | $0.89 B | 57.69% |
| 2021-12-31 | $0.56 B | 47.46% |
| 2020-12-31 | $0.38 B | 382.24% |
| 2019-12-31 | $79.55 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $0.83 B | -16.24% | 🇺🇸 USA |
 Campbell Soup CPB | $0.16 B | -82.95% | 🇺🇸 USA |
 Dow DOW | $3.72 B | 275.69% | 🇺🇸 USA |
 Dupont De Nemours DD | $1.93 B | 95.16% | 🇺🇸 USA |